Description
An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); also inhibits PKA and Cdk2 with IC50 values of 16 and 46 nM, respectively; reduces phosphorylation of Akt downstream targets in cells and slows proliferation of tumor cells both in vitro and in vivo
Formal name: αS-[[[5-(3-methyl-1H-indazol-5-yl)-3-pyridinyl]oxy]methyl]-benzeneethanamine
Synonyms:
Molecular weight: 358.4
CAS: 552325-73-2
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|CDKs||Product Type|Biochemicals|Kinase Inhibitors|PKA||Product Type|Biochemicals|Kinase Inhibitors|PKB/Akt||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Cycle||Research Area|Cancer|Cell Signaling|PI3K/Akt/mTOR Signaling||Research Area|Cell Biology|Cell Signaling|cAMP Signaling||Research Area|Cell Biology|Cell Signaling|PI3K/Akt/mTOR Signaling